Literature DB >> 3183007

Antithrombin III in the diagnosis of infection in febrile neutropenic patients.

C C Kibbler1, H G Prentice, P Noone.   

Abstract

Antithrombin III levels in plasma were measured in 29 febrile neutropenic patients (31 episodes). They were lowest on day 2 in 62.5% of febrile patients and then increased or were normal in 81.3%. Low levels were present on day 2 in only 28.6% of patients with gram-negative infections, as compared with 33% of patients with doubtful infections.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3183007      PMCID： PMC266850          DOI： 10.1128/jcm.26.10.2206-2208.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  8 in total

1.  Mononuclear phagocyte thromboplastin, bacterial counts and endotoxin levels in experimental endogenous gram-negative sepsis.

Authors:  S M Almdahl; B Osterud; K Melby; K E Giercksky
Journal:  Acta Chir Scand       Date:  1986-05

2.  Value of serum C-reactive protein measurement in the management of bone marrow transplant recipients. Part I: Early transplant period.

Authors:  S A Walker; T R Rogers; P G Riches; S White; J R Hobbs
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

3.  Endotoxaemia as a cause of fever in immunosuppressed patients.

Authors:  R I Harris; P C Stone; G R Evans; J Stuart
Journal:  J Clin Pathol       Date:  1984-04       Impact factor: 3.411

4.  Measurement of serum C reactive protein concentration after bone marrow transplantation for leukaemia.

Authors:  I F Rowe; A M Worsley; P Donnelly; D Catovsky; J M Goldman; D Galton; M B Pepys
Journal:  J Clin Pathol       Date:  1984-03       Impact factor: 3.411

5.  Antithrombin-III: clinical significance.

Authors:  J W ten Cate
Journal:  Acta Chir Scand Suppl       Date:  1982

6.  Antithrombin III deficiency in surgical intensive care patients.

Authors:  H G Schipper; J Roos; F vd Meulen; J W ten Cate
Journal:  Thromb Res       Date:  1981 Jan 1-15       Impact factor: 3.944

7.  Value of serum C-reactive protein measurement in the management of bone marrow transplant recipients. Part II: Late post-transplant period.

Authors:  S A Walker; P G Riches; T R Rogers; S White; J R Hobbs
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

8.  Levels of C-reactive protein in patients with hematologic malignancies.

Authors:  A A Kostiala; I Kostiala; V V Valtonen; L Teerenhovi
Journal:  Scand J Infect Dis       Date:  1985
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.